Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer (Q36822111)
Jump to navigation
Jump to search
scientific article published on 23 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer |
scientific article published on 23 May 2011 |
Statements
1 reference
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer (English)
1 reference
Razelle Kurzrock
1 reference
Ravi Salgia
1 reference
Mark J Ratain
1 reference
Ezra E W Cohen
1 reference
Steven I Sherman
1 reference
Douglas W Ball
1 reference
Arlene A Forastiere
1 reference
Roger B Cohen
1 reference
Ranee Mehra
1 reference
David G Pfister
1 reference
Linda Janisch
1 reference
Forlisa Nauling
1 reference
David S Hong
1 reference
Chaan S Ng
1 reference
Lei Ye
1 reference
Robert F Gagel
1 reference
John Frye
1 reference
Thomas Müller
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference